Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Ciloa is a uniquely positioned to support your projects aiming to create new therapeutic.
LoValTech is a mucosal platform that will revolutionize vaccination.
Apmonia Therapeutics is a biotech company that develop therapeutic strategies towards multiple types of cancer.
cosma is a multi-disciplinary expertise in underwater robotics, navigation and data collection at sea, as well as data science.
OSE Immunotherapeutics is an integrated biotechnology company focused on inflammatory disease and cancer treatment.
Aelis Farma is a biotech company that develops pharmaceutical therapies that target chronic and neurodegenerative diseases.
Seederal Technologies is an agricultural machinery manufacturing company that produces electric tractors.
Univity is a space infrastructure company that develops satellite-based connectivity solutions for telecommunications operators.
Aqemia accelerates drug discovery using quantum physics and AI, generating novel drug candidates without experimental data.
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
Hynaero develops the Fregate-F100 amphibious water bomber aircraft for aerial wildfire suppression.
Allogenica develops allogenic CAR-T cells using donor stem cells for cancer treatment.
Jimmy develops and operates thermal generators that supply industrial facilities with process heat produced through nuclear fission.
4Moving Biotech is a biopharmaceutical company that develops osteoarthritis drugs for osteoarthritis patients.
Kikleo provides smart solutions for monitoring the food waste in restaurants and collects and analyzes the data to implement solutions.
Stellaria is reimagining sustainable rapid neutron nuclear energy.
Dillico is a deep technology business that is developing new equipment to simplify and improve the production of mRNA vaccines & medicines.
SiPearl designs European high-performance energy-efficient processors for supercomputing and AI
Thorizon develops and deploys cutting-edge technology for molten salt reactors.
Blue Capsule Technology is a nuclear power company that develops advanced innovative reactors to produce industrial-grade heat.
Hephaistos Pharma is a biotech company developing oncology treatments.
Carbios designs and develops bio-industrial solutions to reinvent the life cycle of plastic and textile polymers.
Oncovita is a biotech company focused on developing innovative medications and vaccines, particularly anti-cancer therapies, to save lives.
AURA AERO aims to serve mankind by designing and manufacturing aircraft that accelerate air transport decarbonization
France 2030 has invested in 48 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
France 2030's top investment sectors include Biotechnology, Medical, Therapeutics, Health Care, Oncology. The firm invests across 49 different industry categories.
Among tracked funding rounds, Hynaero received $135.3M in a Series A round. France 2030's total known invested capital is $623.1M.
France 2030's average investment size is $16.8M across its portfolio of 48 companies.
Recent France 2030 portfolio additions include Ciloa, LoValTech, Apmonia Therapeutics, cosma, OSE Immunotherapeutics. These companies were founded in 2020 or later.